Page 1836 - Williams Hematology ( PDFDrive )

1810 Part XI: Malignant Lymphoid Diseases Chapter 110: Heavy-Chain Disease 1811

REFERENCES 32. Tracy RP, Kyle RA, Leitch JM: Alpha heavy-chain disease presenting as goiter. Am J Clin
Pathol 82:336, 1984.
1. Corcos D, Osborn MJ, Matheson LS: B-cell receptors and heavy chain diseases: Guilty 33. Kim SK, Park IK, Park BH, et al: A case report: Isolated α heavy chain monoclonal gam-
by association? Blood 117:6991, 2011. mopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal
2. Franklin EC, Lowenstein J, Bigelow B, Meltzer M: Heavy chain disease: A new disorder gammopathy and skin change syndrome. Int J Clin Pract Suppl 147:26, 2005.
of serum gamma-globulins: Report of the first case. Am J Med 37:332, 1964. 34. Rambaud JC, Halphen M, Galian A, Tsapis A: Immunoproliferative small intestinal dis-
3. Fermand JP, Brouet JC: Heavy-chain diseases. Hematol Oncol Clin North Am 13:1281, ease (IPSID): Relationships with alpha-chain disease and “Mediterranean” lymphomas.
1999. Springer Semin Immunopathol 12:239, 1990.
4. Fermand JP, Brouet JC, Danon F, Seligmann M: Gamma heavy chain “disease”: Hetero- 35. Tashiro T, Sato H, Takahashi T, et al: Non-secretory alpha chain disease involving stom-
geneity of the clinicopathologic features: Report of 16 cases and review of the literature. ach, small intestine and colon. Intern Med 34:255, 1995.
Medicine (Baltimore) 68:321, 1989. 36. Galian A, Lecestre MJ, Scotto J, et al: Pathological study of alpha-chain disease, with
5. Wahner-Roedler DL, Witzig TE, Loehrer LL, Kyle RA: Gamma-heavy chain disease: special emphasis on evolution. Cancer 39:2081, 1977.
Review of 23 cases. Medicine (Baltimore) 82:236, 2003. 37. Al-Saleem T, Al-Mondhiry H: Immunoproliferative small intestinal disease (IPSID):
6. Wester SM, Banks PM, Li CY: The histopathology of gamma heavy-chain disease. Am J A model for mature B-cell neoplasms. Blood 105:2274, 2005.
Clin Pathol 78:427, 1982. 38. Salem PA, Estephan FF: Immunoproliferative small intestinal disease: Current con-
7. Yunokawa K, Hagiyama Y, Mochizuki Y, et al: Hypertrophic spinal pachymeningitis cepts. Cancer J 11:374, 2005.
associated with heavy-chain disease: Case report. J Neurosurg Spine 7:459, 2007. 39. Martin IG, Aldoori MI: Immunoproliferative small intestinal disease: Mediterranean
8. Sun T, Peng S, Narurkar L: Modified immunoselection technique for definitive diagno- lymphoma and alpha heavy chain disease. Br J Surg 81:20, 1994.
sis of heavy-chain disease. Clin Chem 40:664, 1994. 40. Isaacson PG: Gastrointestinal lymphoma. Hum Pathol 25:1020, 1994.
9. Luraschi P, Infusino I, Zorzoli I, et al: Heavy chain disease can be detected by capillary 41. Berger R, Bernheim A, Tsapis A, et al: Cytogenetic studies in four cases of alpha chain
zone electrophoresis. Clin Chem 51:247, 2005. disease. Cancer Genet Cytogenet 22:219, 1986.
10. Kaleta E, Kyle R, Clark R, Katzmann J: Analysis of patients with γ-heavy chain 42. Pellet P, Tsapis A, Brouet JC: Alpha heavy chain disease of patient MAL: Structure of the
disease by the heavy/light chain and free light chain assays. Clin Chem Lab Med non-functional rearranged alpha gene translocated on chromosome 9. Eur J Immunol
52:665, 2014. 20:2731, 1990.
11. Lee MT, Parwani A, Humphrey R, et al: Gamma heavy chain disease in a patient with 43. Khojasteh A, Saalabian MJ, Haghshenass M: Randomized comparison of abdominal
diabetes and chronic renal insufficiency: Diagnostic assessment of the heavy chain frag- irradiation (AI) vs CHOP vs C-MOPP for the treatment of immunoproliferative small
ment. J Clin Lab Anal 22:146, 2008. intestinal disease (IPSID) associated lymphoma (AL) [abstract]. Proc Annu Meeting Am
12. Lebreton JP, Fontaine M, Rousseaux J, et al: Deleted IgG1 and IgG2 H chains in a Soc Clin Oncol. 2:207, 1983.
patient with an IgG subclass imbalance. Clin Exp Immunol 47:206, 1982. 44. Salimi M, Spinelli JJ: Chemotherapy of Mediterranean abdominal lymphoma: Retro-
13. Keller H, Spengler GA, Skvaril F, et al: [Heavy chain disease: A case of IgG-heavy-chain- spective comparison of chemotherapy protocols in Iranian patients. Am J Clin Oncol
fragment and IgM-type K-paraproteinemia with plasma cell leukemia] [in German]. 19:18, 1996.
Schweiz Med Wochenschr 100:1012, 1970. 45. Ben-Ayed F, Halphen M, Najjar T, et al: Treatment of alpha chain disease: Results of a
14. Woods R, Blumenschein GR, Terry WD: A new type of human gamma heavy chain dis- prospective study in 21 Tunisian patients by the Tunisian-French Intestinal Lymphoma
ease protein: Immunochemical and physical characteristics. Immunochemistry 7:373, Study Group. Cancer 63:1251, 1989.
1970. 46. Hubmann R, Kaiser W, Radaszkiewicz T, et al: Malabsorption associated with a high-
15. Zhang L, Sotomayor EM, Papenhausen PR, et al: Unusual concurrence of T-cell large grade-malignant non-Hodgkin’s lymphoma, alpha-heavy-chain disease and immuno-
granular lymphocytic leukemia with Franklin disease (gamma heavy chain disease) proliferative small intestinal disease. Z Gastroenterol 33:209, 1995.
manifested with massive splenomegaly. Leuk Lymphoma 54:205, 2013. 47. Akbulut H, Soykan I, Yakaryilmaz F, et al: Five-year results of the treatment of
16. Bieliauskas S, Tubbs RR, Bacon CM, et al: Gamma heavy-chain disease: Defining the 23 patients with immunoproliferative small intestinal disease: A Turkish experience.
spectrum of associated lymphoproliferative disorders through analysis of 13 cases. Am Cancer 80:8, 1997.
J Surg Pathol 36:534, 2012. 48. Price SK: Immunoproliferative small intestinal disease: A study of 13 cases with alpha
17. Grogan TM, Muller-Hermelink HK, Van Camp B, et al: Plasma cell neoplasms, in World heavy-chain disease. Histopathology 17:7, 1990.
Health Organization Classification of Tumours: Pathology and Genetics of Tumours of 49. Shih LY, Liaw SJ, Dunn P, Kuo TT: Primary small-intestinal lymphomas in Taiwan:
Haematopoietic and Lymphoid Tissues, edited by Jaffe ES, Harris NL, Stein H, Vardiman Immunoproliferative small-intestinal disease and nonimmunoproliferative small-in-
JW, p 154. IARC Press, Lyon, France, 2001. testinal disease. J Clin Oncol 12:1375, 1994.
18. Tan JN, Kroll MH, O’Hara CJ, et al: Gamma heavy chain disease in a patient with 50. Malik IA, Shamsi Z, Shafquat A, et al: Clinicopathological features and management of
underlying lymphoplasmacytic lymphoma of the thyroid: Report of a case and com- immunoproliferative small intestinal disease and primary small intestinal lymphoma in
parison with other reported cases with thyroid involvement. Clin Chim Acta 413:1696, Pakistan. Med Pediatr Oncol 25:400, 1995.
2012. 51. Demirer T, Uzunalimoglu O, Anderson T, et al: Flow cytometric measurement of pro-
19. Agrawal S, Abboudi Z, Matutes E, Catovsky D: First report of fludarabine in gam- liferation-associated nuclear antigen P105 and DNA content in immuno-proliferative
ma-heavy chain disease. Br J Haematol 88:653, 1994. small intestinal disease (IPSID). J Surg Oncol 58:25, 1995.
20. Ishikawa K, Hirai M, Tsutsumi H, et al: [Successful treatment of heavy-chain disease 52. Vaiphei K, Kumari N, Sinha SK, et al: Roles of syndecan-1, bcl6 and p53 in diagno-
with etoposide] [in Japanese]. Nippon Ronen Igakkai Zasshi 34:221, 1997. sis and prognostication of immunoproliferative small intestinal disease. World J
21. Munshi NC, Digumarthy S, Rahemtullah A: Case records of the Massachusetts General Gastroenterol 12:3602, 2006.
Hospital: Case 13–2008: A 46-year-old man with rheumatoid arthritis and lymphade- 53. Forte FA, Prelli F, Yount W, et al: Heavy chain disease of the μ type: Report of the first
nopathy. N Engl J Med 358:1838, 2008. case. Blood 1970 Aug;36(2):137–44.
22. Takano H, Nagata K, Mikoshiba M, et al: Combination of rituximab and chemother- 54. Wahner-Roedler DL, Kyle RA: Mu-heavy chain disease: Presentation as a benign
apy showing anti-tumor effect in gamma heavy chain disease expressing CD20. Am J monoclonal gammopathy. Am J Hematol 40:56, 1992.
Hematol 83:938, 2008. 55. Witzens M, Egerer G, Stahl D, et al: A case of mu heavy-chain disease associ-
23. Jacobson E, Sharp G, Rimmer J, MacPherson B: A 59-year-old woman with immu- ated with hyperglobulinemia, anemia, and a positive Coombs test. Ann Hematol
notactoid glomerulopathy, heavy-chain disease, and non-Hodgkin lymphoma. Arch 77:231, 1998.
Pathol Lab Med 128:689, 2004. 56. Yanai M, Maeda A, Watanabe N, et al: Successful treatment of mu-heavy chain disease
24. Inoue D, Matsushita A, Kiuchi M, et al: Successful treatment of -heavy-chain disease with fludarabine monophosphate: A case report. Int J Hematol 79:174, 2004.
with rituximab and fludarabine. Acta Haematol 128:139, 2012. 57. Cogne M, Aucouturier P, Brizard A, et al: Complete variable region deletion in a mu
25. Galanti LM, Doyen C, Vander Maelen C, et al: Biological diagnosis of a gamma-1-heavy heavy chain disease protein (ROUL): Correlation with light chain secretion. Leuk Res
chain disease in an asymptomatic patient. Eur J Haematol 54:202, 1995. 17:527, 1993.
26. Seligmann M, Danon F, Hurez D, et al: Alpha-chain disease: A new immunoglobulin 58. Kinoshita K, Yamagata T, Nozaki Y, et al: Mu-heavy chain disease associated with sys-
abnormality. Science 162:1396, 1968. temic amyloidosis. Hematology 9:135, 2004.
27. Makni S, Zouari R, Barbouch MR, et al: [Monoclonal gammopathies in Tunisia] [in 59. Maisnar V, Tichy M, Stulik J, et al: Capillary immunotyping electrophoresis and high
French]. Rev Fr Transfus Hemobiol 33:31, 1990. resolution two-dimensional electrophoresis for the detection of mu-heavy chain dis-
28. Mseddi-Hdiji S, Haddouk S, Ben Ayed M, et al: [Monoclonal gammopathies in Tunisia: ease. Clin Chim Acta 389:171, 2008.
Epidemiological, immunochemical and etiological analysis of 288 cases] [in French]. 60. Marien G, Verhoef G, Bossuyt X: Detection of heavy chain disease by capillary zone
Pathol Biol (Paris) 53:19, 2005. electrophoresis. Clin Chem 51:1302, 2005.
29. Lankarani KB, Masoompour SM, Masoompour MB, et al: Changing epidemiology of 61. Gordon J, Hamblin TJ, Smith JL, et al. A human B-cell lymphoma synthesizing and
IPSID in southern Iran. Gut 54:311, 2005. expressing surface mu-chain in the absence of detectable light chain. Blood 58:552,
30. Economidou I, Manousos ON, Triantafillidis JK, et al: Immunoproliferative small intes- 1981.
tinal disease in Greece: Presentation of 13 cases including two from Albania. Eur J Gas- 62. Guglielmo P, Granata P, Di Raimondo F, et al: “Mu” heavy chain type “non-excretory”
troenterol Hepatol 18:1029, 2006. myeloma. Scand J Haematol 29:36, 1982.
31. Lecuit M, Abachin E, Martin A, et al: Immunoproliferative small intestinal disease 63. Leglise MC, Briere J, Abgrall JF, Hurez D: [Non-secretory myeloma of heavy mu-chain
associated with Campylobacter jejuni. N Engl J Med 350:239, 2004. type] [in French]. Nouv Rev Fr Hematol 25:103, 1983.

Kaushansky_chapter 110_p1803-1812.indd 1811 9/18/15 10:00 AM